Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
CERo Therapeutics Holdings Inc. Warrants (OTC : CEROW) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company¿s proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body¿s full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies.
Quote
| Last: | $0.0015 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0015 |
| Close: | $0.0015 |
| High: | $0.0015 |
| Low: | $0.0015 |
| Volume: | 2,500 |
| Last Trade Date Time: | 06/22/2026 12:55:54 pm |
Stock Data
| Market Cap: | $1,419,782 |
|---|---|
| Float: | 19,556,591 |
| Insiders Ownership: | N/A |
| Institutions: | 30 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.cero.bio |
| Country: | US |
| City: | South San Francisco |
**MWN-AI FAQ is based on asking OpenAI questions about CERo Therapeutics Holdings Inc. Warrants (OTC: CEROW).
